BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Mountain Standard Time BEGIN:STANDARD DTSTART:20231102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Mountain Standard Time TZOFFSETFROM:-0600 TZOFFSETTO:-0700 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Mountain Daylight Time TZOFFSETFROM:-0700 TZOFFSETTO:-0600 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Gain insights into clinical trial design\, practical tips\, str ategies and risks. \;\n\nPresented by \;Howard Golub\, MD PhD.&nbs p\;\nPrincipal of Core-Safe LLC\n\nSerial entrepreneur\; founder of Battel leCRO Inc\, PDS Inc. a medical computer-based diagnostic device company\, Cry Research Inc. and DcTek Inc\, where technology from his patent was use d for a device that permits continuous\, cuffless\, non-invasive measureme nt of blood pressure\n\nFormer VP Clinical Research\, Walgreens\n\nHolds a n appointment as Senior Lecturer\nin the M.I.T.-Harvard Joint Program\n\nS erved as Sr. Consultant/Head of New\nVentures for Transform Pharmaceutical s\n(a Johnson &\; Johnson company) DTEND:20190307T020000Z DTSTAMP:20240328T235701Z DTSTART:20190307T000000Z LOCATION: SEQUENCE:0 SUMMARY:SPARK 16: Clinical Trial Considerations UID:RFCALITEM638472454211051401 X-ALT-DESC;FMTTYPE=text/html:
Gain insights into clinical trial design\,
practical tips\, strategies and risks. \;
\n
\nPresented by&
nbsp\;Howard Golub\, MD PhD. \;
\nPrincipal of Core-Safe LLC
\n
\nSerial entrepreneur\; founder of BattelleCRO Inc\, PDS Inc. a m
edical computer-based diagnostic device company\, Cry Research Inc. and Dc
Tek Inc\, where technology from his patent was used for a device that perm
its continuous\, cuffless\, non-invasive measurement of blood pressure
\n
\nFormer VP Clinical Research\, Walgreens
\n
\nHolds a
n appointment as Senior Lecturer
\nin the M.I.T.-Harvard Joint Progra
m
\n
\nServed as Sr. Consultant/Head of New
\nVentures for
Transform Pharmaceuticals
\n(a Johnson &\; Johnson company)